In the US, Letrozole (letrozole systemic) is a member of the following drug classes: aromatase inhibitors, hormones/antineoplastics and is used to treat Breast Cancer, Breast Cancer - Adjuvant, Breast Cancer - Metastatic and Female Infertility.
US matches:
- Letrozole
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
L02BG04
CAS registry number (Chemical Abstracts Service)
0112809-51-5
Chemical Formula
C17-H11-N5
Molecular Weight
285
Therapeutic Categories
Antineoplastic agent
Enzyme inhibitor, aromatase
Chemical Name
Benzonitrile, 4,4'-(1H-1,2,4-triazol-1-ylmethylene)bis-
Foreign Names
- Letrozolum (Latin)
- Letrozol (German)
- Letrozole (French)
- Letrozol (Spanish)
Generic Names
- Letrozole (OS: USAN, BAN)
- CGS 20267 (IS: Ciba-Geigy)
- Letrozole (PH: USP 32, Ph. Eur. 5, BP 2010)
- Letrozolum (PH: Ph. Eur. 6)
Brand Names
- Aromek
Celon, Poland - Cendalon
Teva, Argentina - Etruzil
Egis, Slovakia - Fecinole
Dosa, Argentina; Medigroup, Peru - Femaplex
Genepharm, Greece - Femar
Novartis, Denmark; Novartis, Finland; Novartis, Iceland; Novartis, Norway; Novartis, Sweden - Femara
Delphi, Netherlands; Euro, Netherlands; Novartis, United Arab Emirates; Novartis, Argentina; Novartis, Austria; Novartis, Australia; Novartis, Bosnia & Herzegowina; Novartis, Bangladesh; Novartis, Belgium; Novartis, Bulgaria; Novartis, Bahrain; Novartis, Brazil; Novartis, Canada; Novartis, Switzerland; Novartis, Chile; Novartis, China; Novartis, Colombia; Novartis, Czech Republic; Novartis, Germany; Novartis, Ecuador; Novartis, Estonia; Novartis, Egypt; Novartis, Spain; Novartis, United Kingdom; Novartis, Greece; Novartis, Hong Kong; Novartis, Croatia (Hrvatska); Novartis, Hungary; Novartis, Indonesia; Novartis, Ireland; Novartis, Israel; Novartis, Iraq; Novartis, Iran; Novartis, Italy; Novartis, Jordan; Novartis, Japan; Novartis, Kuwait; Novartis, Lebanon; Novartis, Sri Lanka; Novartis, Lithuania; Novartis, Luxembourg; Novartis, Latvia; Novartis, Malta; Novartis, Mexico; Novartis, Malaysia; Novartis, Netherlands; Novartis, New Zealand; Novartis, Oman; Novartis, Philippines; Novartis, Poland; Novartis, Portugal; Novartis, Qatar; Novartis, Romania; Novartis, Serbia; Novartis, Russian Federation; Novartis, Saudi Arabia; Novartis, Singapore; Novartis, Slovenia; Novartis, Slovakia; Novartis, Syria; Novartis, Thailand; Novartis, Turkey; Novartis, Taiwan; Novartis, United States; Novartis, Venezuela; Novartis, Vietnam; Novartis, Yemen; Novartis, South Africa; Novartis Pharmaceuticals, Peru - Fémara
Novartis, France; Novartis, France; Novartis, Tunisia; Novartis, Tunisia - Femtozone
Helm, Slovakia - Kebirzol
Aspen, Argentina - Lametta
Vipharm, Poland - Leoncol
Pharmanel, Greece - Letrol
Renata, Bangladesh - Letropen
Elpen, Greece - Letroz
Sun, Myanmar - Letrozin
Meditrina, Greece - Letrozol Microsules
Microsules, Argentina - Letrozol Nucleus
Rottendorf, Bulgaria; Synthon, Bulgaria; Synthon, Bulgaria - Letrozol Sandoz
Lek, Bulgaria; Rottendorf, Bulgaria; Sandoz, Slovakia; Synthon, Bulgaria - Letrozol Streuli
Streuli Pharma, Switzerland - Letrozol Teva
Teva, Slovakia - Letrozole Helm
Medihelm, Greece - Letrozole Medico Uno
Medico Uno, Slovakia - Letrozol-Mepha
Mepha Pharma, Switzerland - Letrozolum Genthon
Genthon, Slovakia - Letrozolum Polpharma
Polpharma, Slovakia - Letrozolum Synthon
Synthon, Slovakia - Levinox
Santa, Greece - Linol
Vianex / BIANEΞ, Greece - Loosyn
Synthon, Slovakia - Losiral
Farmindustria, Peru; Neoraxis, Chile; Recalcine, Ecuador - Loxifan
Padro, Spain - Mimor
png Gerolymatos, Greece - Picozone
Helm, Slovakia - Trozet
Dabur, India
International Drug Name Search
Glossary
BAN | British Approved Name |
IS | Inofficial Synonym |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment